Username Password
S&P 500: 1,070.52 Change: +1.30%

VIROPHARMA INCORPORATED (VPHM)

Overview
Price $9.74
Price change for today in $ +$0.35
Price change for today in % +3.73%
P&P rating Rating: 4
Open Price $13.32
Previous close $9.39
Daily Range $9.32 - $9.80
52-Week Range $3.79 - $10.74
Volume 911,066
chart
Rate this Stock!
You haven't rated this stock yet!

What The Community Thinks

Total Players

130 Buy
0 Sell
 
Top Buy Analysis
BUY: VPHM Rating: 4
Company: VIROPHARMA INCORPORATED
Points: -2.05
Start Price: $11.98
Start Date: 07/30/2008 8:52 AM
LeveneOMurray
LeveneOMurray
P&P Score: 99.96
Recs:
Good Q2 earnings

Comments: 0 | Comment


Top Sell Analysis
No Sell Analysis. Be the First.
Picks
Username P&P Score Call Time Frame Start Date Start Price Today (change) Stock Gain S&P Gain Points Analysis
smallfish BUY One to Three Months 05/18/2009 $6.17 $9.74
(+3.73%)
+57.86% +17.88% +39.98
f1ndforty 98.81 BUY Six Months to a Year 04/03/2009 $5.31 $9.74
(+3.73%)
+83.43% +27.06% +56.36 view
JoeThePlumber 99.55 BUY One to Three Months 02/10/2009 $6.19 $9.74
(+3.73%)
+57.35% +29.42% +27.93 view
DemonSeed 99.57 BUY Six Months to a Year 12/19/2008 $12.87 $9.74
(+3.73%)
-24.32% +22.82% -47.14 view
rebeldusk 68.75 BUY Six Months to a Year 12/04/2008 $11.56 $9.74
(+3.73%)
-15.74% +22.20% -37.94 view
deviljix 1.76 BUY Six Months to a Year 08/21/2008 $13.83 $9.74
(+3.73%)
-29.57% -16.22% -13.36
LeveneOMurray 99.96 BUY Week or Less 07/30/2008 $11.98 $9.74
(+3.73%)
-18.70% -16.64% -2.05 view
SP500 0.11 BUY Three to Six Months 07/08/2008 $11.72 $9.74
(+3.73%)
-16.89% -13.99% -2.90
uptensweet 99.98 BUY Three to Six Months 07/03/2008 $10.83 $9.74
(+3.73%)
-10.06% -14.52% +4.45
beamco 26.33 BUY Six Months to a Year 01/01/2008 $7.94 $9.74
(+3.73%)
+22.67% -26.03% +48.70
Pages: [ 1 ]  2   3   4   5   ...  13  >>
Commentary
BUY: VIROPHARMA INCORPORATED (VPHM) Rating: 4
Start Price: $6.19
Points: +27.93
Created: 02/10/2009
Outperform.

Comments: 0 | Comment

Recs:
 
BUY: VIROPHARMA INCORPORATED (VPHM) Rating: 4
Start Price: $12.87
Points: -47.14
Created: 12/19/2008
Low PEG, beating estimates, estimates revised upwards, high growth rate, decreasing debt to equity and debt to capital.

This is a pharmaceutical company. The health care sector is typically not affected as much as other sectors of the economy during economic downturns.

Comments: 0 | Comment

Recs:
 
BUY: VIROPHARMA INCORPORATED (VPHM) Rating: 4
Start Price: $11.56
Points: -37.94
Created: 12/04/2008
Sales are expected to grow 159.26%.

Comments: 0 | Comment

Recs:
 
BUY: VIROPHARMA INCORPORATED (VPHM) Rating: 4
Start Price: $11.98
Points: -2.05
Created: 07/30/2008
Good Q2 earnings

Comments: 0 | Comment

Recs:
 
BUY: VIROPHARMA INCORPORATED (VPHM) Rating: 4
Start Price: $6.17
Points: +39.98
Created: 05/18/2009

Comments: 0 | Comment

Recs:
 
BUY: VIROPHARMA INCORPORATED (VPHM) Rating: 4
Start Price: $5.31
Points: +56.36
Created: 04/03/2009
do it

Comments: 0 | Comment

Recs:
 
BUY: VIROPHARMA INCORPORATED (VPHM) Rating: 4
Start Price: $13.83
Points: -13.36
Created: 08/21/2008

Comments: 0 | Comment

Recs:
 
BUY: VIROPHARMA INCORPORATED (VPHM) Rating: 4
Start Price: $11.72
Points: -2.90
Created: 07/08/2008

Comments: 0 | Comment

Recs:
 
BUY: VIROPHARMA INCORPORATED (VPHM) Rating: 4
Start Price: $10.83
Points: +4.45
Created: 07/03/2008

Comments: 0 | Comment

Recs:
 
BUY: VIROPHARMA INCORPORATED (VPHM) Rating: 4
Start Price: $7.94
Points: +48.70
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
Pages: [ 1 ]  2   3   4   5   ...  13  >>
Sponsored Links